Universität zu Köln

Seemueller, Florian, Schennach, Rebecca, Mayr, Andreas ORCID: 0000-0001-7106-9732, Musil, Richard ORCID: 0000-0002-0792-8413, Jaeger, Markus, Maier, Wolfgang, Klingenberg, Stefan, Heuser, Isabella, Klosterkoetter, Joachim, Gastpar, Markus, Schmitt, Andrea ORCID: 0000-0002-5426-4023, Schloesser, Ralf, Schneider, Frank ORCID: 0000-0003-1557-7956, Ohmann, Christian, Lewitzka, Ute, Gaebel, Wolfgang, Moeller, Hans-Juergen and Riedel, Michael (2012). Akathisia and Suicidal Ideation in First-Episode Schizophrenia. J. Clin. Psychopharmacol., 32 (5). S. 694 - 699. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1533-712X

Full text not available from this repository.

Abstract

Patients with first-episode schizophrenia (FES) are known to be notably sensitive for developing extrapyramidal adverse effects, but the relation of akathisia and suicidal ideation has rarely been studied. The current report is an ongoing analysis of an 8-week double-blind randomized controlled multicenter trial in 289 FES, comparing risperidone and haloperidol. Assessments were conducted weekly and included the Hillside Akathisia Scale and 21-item Hamilton Depression Rating Scale ratings. Suicidal ideation was significantly associated with clinician observed akathisia, depressed mood, younger age, and use of propranolol. The allocated treatment, anxiety, and nervousness had no influence. The present findings suggest a promoting effect of akathisia on suicidal ideation can not be ruled out in patients with FES.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Seemueller, Florian UNSPECIFIED UNSPECIFIED UNSPECIFIED Schennach, Rebecca UNSPECIFIED UNSPECIFIED UNSPECIFIED Mayr, Andreas UNSPECIFIED orcid.org/0000-0001-7106-9732 UNSPECIFIED Musil, Richard UNSPECIFIED orcid.org/0000-0002-0792-8413 UNSPECIFIED Jaeger, Markus UNSPECIFIED UNSPECIFIED UNSPECIFIED Maier, Wolfgang UNSPECIFIED UNSPECIFIED UNSPECIFIED Klingenberg, Stefan UNSPECIFIED UNSPECIFIED UNSPECIFIED Heuser, Isabella UNSPECIFIED UNSPECIFIED UNSPECIFIED Klosterkoetter, Joachim UNSPECIFIED UNSPECIFIED UNSPECIFIED Gastpar, Markus UNSPECIFIED UNSPECIFIED UNSPECIFIED Schmitt, Andrea UNSPECIFIED orcid.org/0000-0002-5426-4023 UNSPECIFIED Schloesser, Ralf UNSPECIFIED UNSPECIFIED UNSPECIFIED Schneider, Frank UNSPECIFIED orcid.org/0000-0003-1557-7956 UNSPECIFIED Ohmann, Christian UNSPECIFIED UNSPECIFIED UNSPECIFIED Lewitzka, Ute UNSPECIFIED UNSPECIFIED UNSPECIFIED Gaebel, Wolfgang UNSPECIFIED UNSPECIFIED UNSPECIFIED Moeller, Hans-Juergen UNSPECIFIED UNSPECIFIED UNSPECIFIED Riedel, Michael UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-482120
DOI:	10.1097/JCP.0b013e3182677958
Journal or Publication Title:	J. Clin. Psychopharmacol.
Volume:	32
Number:	5
Page Range:	S. 694 - 699
Date:	2012
Publisher:	LIPPINCOTT WILLIAMS & WILKINS
Place of Publication:	PHILADELPHIA
ISSN:	1533-712X
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language BIOLOGICAL-PSYCHIATRY WFSBP; WORLD-FEDERATION; TERM TREATMENT; TRIAL; SCALE; HALOPERIDOL; ASSOCIATION; RISPERIDONE; GUIDELINES; SOCIETIES Multiple languages Pharmacology & Pharmacy; Psychiatry Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/48212